Home

Veľmi nahnevaný dôsledky pohostinstvá webb jordan 2017 ovarian cancer prímerie chaos noha

IJMS | Free Full-Text | Strategy for Pre-Clinical Development of Active  Targeting MicroRNA Oligonucleotide Therapeutics for Unmet Medical Needs
IJMS | Free Full-Text | Strategy for Pre-Clinical Development of Active Targeting MicroRNA Oligonucleotide Therapeutics for Unmet Medical Needs

Exploiting epigenetic dependencies in ovarian cancer therapy - Coughlan -  2021 - International Journal of Cancer - Wiley Online Library
Exploiting epigenetic dependencies in ovarian cancer therapy - Coughlan - 2021 - International Journal of Cancer - Wiley Online Library

PDF) Nitrogen-Based Bisphosphonate Use and Ovarian Cancer Risk in Women  Aged 50 Years and Older
PDF) Nitrogen-Based Bisphosphonate Use and Ovarian Cancer Risk in Women Aged 50 Years and Older

METTL3 promotes the initiation and metastasis of ovarian cancer by  inhibiting CCNG2 expression via promoting the maturation of  pri-microRNA-1246 | Cell Death Discovery
METTL3 promotes the initiation and metastasis of ovarian cancer by inhibiting CCNG2 expression via promoting the maturation of pri-microRNA-1246 | Cell Death Discovery

Statin use and survival among women with ovarian cancer: an Australian  national data-linkage study
Statin use and survival among women with ovarian cancer: an Australian national data-linkage study

Ovarian Cancer Immunotherapy en Route: IL9 Inhibits Growth of Ovarian Cancer  and Upregulates its Expression of Ox40L and 4-1BBL
Ovarian Cancer Immunotherapy en Route: IL9 Inhibits Growth of Ovarian Cancer and Upregulates its Expression of Ox40L and 4-1BBL

Frontiers | Association Between Benign Ovarian Tumors and Ovarian Cancer  Risk: A Meta-Analysis of Ten Epidemiological Studies
Frontiers | Association Between Benign Ovarian Tumors and Ovarian Cancer Risk: A Meta-Analysis of Ten Epidemiological Studies

Shifting incidence and survival of epithelial ovarian cancer (1995‐2014): A  SurvMark‐2 study - Cabasag - 2023 - International Journal of Cancer - Wiley  Online Library
Shifting incidence and survival of epithelial ovarian cancer (1995‐2014): A SurvMark‐2 study - Cabasag - 2023 - International Journal of Cancer - Wiley Online Library

Epidemiology of epithelial ovarian cancer - ScienceDirect
Epidemiology of epithelial ovarian cancer - ScienceDirect

A machine learning approach to identify predictive molecular markers for  cisplatin chemosensitivity following surgical resection in ovarian cancer |  Scientific Reports
A machine learning approach to identify predictive molecular markers for cisplatin chemosensitivity following surgical resection in ovarian cancer | Scientific Reports

Cancers | Free Full-Text | An Overview of Candidate Therapeutic Target  Genes in Ovarian Cancer
Cancers | Free Full-Text | An Overview of Candidate Therapeutic Target Genes in Ovarian Cancer

Bibliometric analysis of hotspots and frontiers in cancer-related fatigue  among ovarian cancer survivors | PLOS ONE
Bibliometric analysis of hotspots and frontiers in cancer-related fatigue among ovarian cancer survivors | PLOS ONE

Cancers | Free Full-Text | Current and Emerging Methods for Ovarian Cancer  Screening and Diagnostics: A Comprehensive Review
Cancers | Free Full-Text | Current and Emerging Methods for Ovarian Cancer Screening and Diagnostics: A Comprehensive Review

The epigenetic correlation among ovarian cancer, endometriosis and PCOS: A  review - ScienceDirect
The epigenetic correlation among ovarian cancer, endometriosis and PCOS: A review - ScienceDirect

Associate Professor Susan Jordan - School of Public Health - University of  Queensland
Associate Professor Susan Jordan - School of Public Health - University of Queensland

Bibliometric analysis of hotspots and frontiers in cancer-related fatigue  among ovarian cancer survivors | PLOS ONE
Bibliometric analysis of hotspots and frontiers in cancer-related fatigue among ovarian cancer survivors | PLOS ONE

Frontiers | Pre-diagnosis Cruciferous Vegetables and Isothiocyanates Intake  and Ovarian Cancer Survival: A Prospective Cohort Study
Frontiers | Pre-diagnosis Cruciferous Vegetables and Isothiocyanates Intake and Ovarian Cancer Survival: A Prospective Cohort Study

Cells | Free Full-Text | Hereditary Ovarian Carcinoma: Cancer Pathogenesis  Looking beyond BRCA1 and BRCA2
Cells | Free Full-Text | Hereditary Ovarian Carcinoma: Cancer Pathogenesis Looking beyond BRCA1 and BRCA2

Cancers | Free Full-Text | Worldwide Burden, Risk Factors, and Temporal  Trends of Ovarian Cancer: A Global Study
Cancers | Free Full-Text | Worldwide Burden, Risk Factors, and Temporal Trends of Ovarian Cancer: A Global Study

Biomedicines | Free Full-Text | The Role of the Adipokine Resistin in the  Pathogenesis and Progression of Epithelial Ovarian Cancer
Biomedicines | Free Full-Text | The Role of the Adipokine Resistin in the Pathogenesis and Progression of Epithelial Ovarian Cancer

An epidemiologic risk prediction model for ovarian cancer in Europe: the  EPIC study | British Journal of Cancer
An epidemiologic risk prediction model for ovarian cancer in Europe: the EPIC study | British Journal of Cancer

Medicina | Free Full-Text | Progression Free Survival, Overall Survival,  and Relapse Rate in Endometrioid Ovarian Cancer and Synchronous Endometrial- Ovarian Endometrioid Cancer (SEO-EC): Results from a Large Retrospective  Analysis
Medicina | Free Full-Text | Progression Free Survival, Overall Survival, and Relapse Rate in Endometrioid Ovarian Cancer and Synchronous Endometrial- Ovarian Endometrioid Cancer (SEO-EC): Results from a Large Retrospective Analysis

IJMS | Free Full-Text | Gene Expression Indicates Altered Immune Modulation  and Signaling Pathway Activation in Ovarian Cancer Patients Resistant to  Topotecan
IJMS | Free Full-Text | Gene Expression Indicates Altered Immune Modulation and Signaling Pathway Activation in Ovarian Cancer Patients Resistant to Topotecan

PDF) The anti-IgE monoclonal antibody omalizumab as adjuvant treatment in  desensitization to carboplatin in patients with ovarian cancer
PDF) The anti-IgE monoclonal antibody omalizumab as adjuvant treatment in desensitization to carboplatin in patients with ovarian cancer

Frontiers | Identification of NAD+ Metabolism-Derived Gene Signatures in Ovarian  Cancer Prognosis and Immunotherapy
Frontiers | Identification of NAD+ Metabolism-Derived Gene Signatures in Ovarian Cancer Prognosis and Immunotherapy

Blood bioactive sphingolipids in patients with advanced serous epithelial ovarian  cancer – mass spectrometry analysis
Blood bioactive sphingolipids in patients with advanced serous epithelial ovarian cancer – mass spectrometry analysis

Frontiers | Stress Hormones: Emerging Targets in Gynecological Cancers
Frontiers | Stress Hormones: Emerging Targets in Gynecological Cancers